No apparent association between periocular and ocular microcolonization and the degree of inflammation in patients with atopic keratoconjunctivitis

Clinical and Experimental Allergy

Volumn 34, Issue 5, 2004, Pages 725-730

  Nivenius, E ^a   Montan, P G ^a   Chryssanthou, E ^b   Jung, K ^b   Van Hage Hamsten, M ^c   Van Der Ploeg, I ^a  

^a ST ERIK S EYE HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Atopic dermatitis eczema syndrome; Atopic keratoconjunctivitis; Cytokine; Eye; IgE; Malassezia; Staphylococcus; Tear

Indexed keywords

BACTERIAL ANTIGEN; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AEROBIC BACTERIUM; AGED; ARTICLE; ATOPY; BACTERIUM ISOLATE; CLINICAL ARTICLE; CLINICAL FEATURE; CONJUNCTIVAL BIOPSY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FUNGUS; HUMAN; HUMAN TISSUE; INFLAMMATION; KERATOCONJUNCTIVITIS; LACRIMAL FLUID; MALASSEZIA; MALE; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

ADULT; AGED; ANTIGENS, BACTERIAL; ANTIGENS, FUNGAL; CASE-CONTROL STUDIES; CONJUNCTIVA; CONJUNCTIVITIS, ALLERGIC; EYE INFECTIONS; EYE INFECTIONS, BACTERIAL; EYE INFECTIONS, FUNGAL; FEMALE; HUMANS; IMMUNOGLOBULIN E; INTERFERON TYPE II; INTERLEUKINS; MALE; MIDDLE AGED; STAPHYLOCOCCUS AUREUS; TEARS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 2942521493     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2004.1950.x     Document Type: Article

References (27)

1. Johansson SG, Hourihane JO, Bousquet J et al. A revised nomenclature for allergy: an EAACI Position Statement from the EAACI Nomenclature Task Force. Allergy 2001; 56:813-24.
2. Garrity JA, Liesegang TJ. Ocular complications of atopic dermatitis. Can J Ophthalmol 1984; 19:21-4.
3. Thepen T, Langeveld-Wildschut EG, Bihari IC et al. Biphasic response against aeroallergen in atopic dermatitis showing a switch from an initial TH2 response to a TH1 response in situ: an immunocytochemical study. J Allergy Clin Immunol 1996; 97:828-37.
4. Metz DP, Hingorani M, Calder VL, Buckley RJ, Lightman SL. T-cell cytokines in chronic allergic eye disease. J Allergy Clin Immunol 1997; 100:817-24.
5. Uchio E, Ono SY, Ikezawa Z, Ohno S. Tear levels of interferon-gamma, interleukin (IL) -2, IL-4 and IL-5 in patients with vernal keratoconjunctivitis, atopic keratoconjunctivitis and allergic conjunctivitis. Clin Exp Allergy 2000; 30:103-9.
6. Breuer K, Häussler S, Kapp A, Werfel T. Staphylococcus aureus: colonizing features and influence of an antibacterial treatment in adults with atopic dermatitis. Br J Dermatol 2002; 147:55-61.
7. Lintu P, Savolainen J, Kortekangas-Sovolainen O, Kalimo K. Systemic ketokonazole is an effective treatment of atopic dermatitis with IgE-mediated hypersensitivity to yeasts. Allergy 2001; 56:512-7.
8. Leeming JP, Notman FH. Improved methods for isolation and enumeration of Malassezia furfur from human skin. J Clin Microbiol 1987; 10:2017-9.
9. Murray PR. Manual of clinical microbiology, 7th Edn. Washington DC: American Society for Microbiology, 1999.
10. Nakabayashi A, Sei Y, Guillot J. Identification of Malassezia species isolated from patients with seborrhoeic dermatitis, atopic dermatitis, pityriasis versicolor and normal subjects. Med Mycol 2000; 38:337-41.
11. Cook EB, Stahl JL, Lowe L et al. Simultaneous measurement of six cytokines in a single sample of human tears using microparticle-based flow cytometry: allergies vs. non-allergies. J Immunol Methods 2001; 254:109-18.
12. Montan PG, Scheynius A, van der Ploeg I. Similar T helper Th2-like cytokine mRNA expression in vernal keratoconjunctivitis regardless of atopic constitution. Allergy 2002; 57:436-41.
13. Higaki S, Morohashi M, Yamagishi T, Hasegawa Y. Comparative study of staphylococci from the skin of atopic dermatitis patients and from healthy subjects. Int J Dermatol 1999; 38:265-9.
14. Bunikowski R, Mielke M, Skarabis H et al. Prevalence and role of serum IgE antibodies to the Staphylococcus aureus-derived superantigens SEA and SEB in children with atopic dermatitis. J Allergy Clin Immunol 1999; 103:119-24.
15. Nordvall SL, Lindgren L, Johansson SG, Johansson S, Petrini B. IgE antibodies to Pityrosporum orbiculare and Staphylococcus aureus in patients with very high serum total IgE. Clin Exp Allergy 1992; 22:756-61.
16. Broberg A, Faergemann J. Topical antimycotic treatment of atopic dermatitis in the head/neck area. A double-blind randomised study. Acta Derm Venereol 1995; 75:46-9.
17. Ewing CI, Ashcroft C, Gibbs AC, Jones GA, Connor PJ, David TJ. Flucloxacillin in the treatment of atopic dermatitis. Br J Dermatol 1998; 138:1022-9.
18. Huber-Spitzy V, Böhler-Sommeregger K, Arocker-Mettinger E, Grabner G. Ulcerative blepharitis in atopic patients - is Candida species the causative agent? Br J Ophthalmol 1992; 76:272-4.
19. Tuft SJ, Kemeny DM, Dart JK, Buckley RJ. Clinical features of atopic keratoconjunctivitis. Ophthalmology 1991; 98:150-8.
20. Nakata K, Inoue Y, Harada J et al. A high incidence of Staphylococcus aureus colonization in the external eyes of patients with atopic dermatitis. Ophthalmology 2000; 107:2167-71.
21. Arikawa J, Ishibashi M, Kawashima M, Takagi Y, Ichikawa Y, Imokawa G. Decreased levels of sphingosine, a natural antimicrobial agent, may be associated with vulnerability of the stratum corneum from patients with atopic dermatitis to colonization by Staphylococcus aureus. J Invest Dermatol 2002; 119:433-9.
22. Ong PY, Ohtake T, Brandt C et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002; 347:1151-60.
23. Campbell DE, Kemp AS. Proliferation and production of interferon-gamma (IFN-gamma) and IL-4 in response to Staphylococcus aureus and staphylococcal superantigen in childhood atopic dermatitis. Clin Exp Immunol 1997; 107:392-7.
24. Gupta AK, Kohli Y, Summerbell RC, Faergemann J. Quantitative culture of Malassezia species from different body sites of individuals with or without dermatoses. Med Mycol 2001; 39:243-51.
25. Nomura I, Tanaka K, Tomita H et al. Evaluation of the staphylococcal exotoxins and their specific IgE in childhood atopic dermatitis. J Allergy Clin Immunol 1999; 104:441-6.
26. Breuer K, Wittmann M, Bösche B, Kapp A, Werfel T. Severe atopic dermatitis is associated with sensitization to staphylococcal enterotoxin B (SEB). Allergy 2000; 55:551-5.
27. Bäck O, Bartosik J. Systemic ketokonazole for yeast allergic patients with atopic dermatitis. J Eur Acad Dermatol Venereol 2001; 15:34-8.